MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for patients with Parkinson’s disease and motor fluctuations: Results from the Phase 3 randomized, active-controlled BouNDless study

    O. Rascol, A. Albanese, A. Ellenbogen, J. Ferreira, N. Giladi, T. Gurevich, S. Hassin-Baer, J. Hernandez-Vara, S. Isaacson, K. Kieburtz, P. Lewitt, L. Lopez-Manzanares, CW. Olanow, R. Pahwa, W. Poewe, H. Sarva, F. Stocchi, T. Yardeni, L. Adar, L. Salin, N. Lopes, N. Sasson, R. Case, A. Espay (Toulouse, France)

    Objective: Determine the efficacy, safety, and tolerability of ND0612 versus oral immediate-release levodopa/carbidopa (IR-LD/CD) in people with Parkinson’s disease (PwP) experiencing motor fluctuations. Background: ND0612…
  • 2023 International Congress

    Post encephalitic dystonia-ataxia syndrome

    A. Elavarasi, F. Mustafa, A. Garg, M. Tripathi, D. Vibha, R. Singh, B. Mishra (New Delhi, India)

    Objective: To describe a young man with post encephalitc dystonia-ataxia with transient worsening following a febrile episode Background: We had a 19 year old young…
  • 2023 International Congress

    The effects of mental imagery on balance, anxiety and quality of life of older people with early stage of dementia: Preliminary data

    C. Bouzineki, A. Christakou (Athens, Greece)

    Objective: To examine the effectiveness of MI on balance; anxiety and quality of life of older adults with early stage of dementia. Background: Dementia is…
  • 2023 International Congress

    Efficacy of perampanel in paroxysmal kinesigenic dyskinesia

    Z. Li, X. Huang, L. Cao (Shanghai, China)

    Objective: To explore the efficacy and safety of perampanel in the treatment of paroxysmal kinesigenic dyskinesia (PKD) Background: Perampanel is a new type of antiepileptic…
  • 2023 International Congress

    Continuous subcutaneous foslevodopa/foscarbidopa: final results from a phase 3, open-label study

    J. Aldred, A. Amelin, A. Antonini, B. Bergmans, F. Bergquist, M. Bouchard, K. Budur, C. Carroll, K. Chaudhuri, S. Criswell, E. Danielsen, E. Freire Alvarez, F. Gandor, J. Jia, T. Kimber, H. Mochizuki, W. Robieson, A. Spiegel, D. Standaert, S. Talapala, M. Facheris, V. Fung (Spokane, USA)

    Objective: Evaluate safety and efficacy of foslevodopa/foscarbidopa (LDP/CDP) for patients with Parkinson’s disease (PD) in a 52-week, phase 3 study. Background: As PD progresses, patients…
  • 2023 International Congress

    Consideration of age and initial putaminal rim segment in distinguishing multiple system atrophy parkinsonian type

    W. Lee (Seoul, Republic of Korea)

    Objective: To improve diagnostic performance in distinguishing multiple system atrophy parkinsonian type (MSA-p), we investigated the iron deposition pattern in the putaminal lateral margin of…
  • 2023 International Congress

    Longitudinal CSF measurements of alpha-synuclein, amyloid beta and tau in Parkinson disease

    R. Miller, A. Li, M. Campbel, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

    Objective: To evaluate whether cerebrospinal fluid (CSF) levels of alpha synuclein (Asyn), amyloid beta (Aβ) and tau change with disease progression and to evaluate whether…
  • 2023 International Congress

    Analysis of levodopa use in patients with Parkinson’s Disease during pregnancy: a systematic review of the last twenty years

    R. Albuquerque, E. Almeida, G. Herwig, G. Bolner, G. Maia, G. Mantovani, MF. Felippe, V. Müller (Porto Alegre, Brazil)

    Objective: To evaluate the role of oral levodopa in patients with Parkinson’s disease (PD) during pregnancy, using the available literature, in order to determine the…
  • 2023 International Congress

    Asymmetry and side concordance of rest tremor and bradykinesia in patients with essential tremor

    L. Angelini, G. Paparella, D. Costa, D. Birreci, A. Cannavacciuolo, M. Passaretti, D. Colella, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: In the present study, we aimed to investigate the clinical and kinematic features of rest tremor and bradykinesia in patients with essential tremor (ET),…
  • 2023 International Congress

    Staged and simultaneous bilateral MRI-guided focused ultrasound treatment of essential tremor

    R. Galimova, D. Nabiullina, S. Illarioshkin, I. Buzaev, S. Safin, G. Akhmadeeva (Ufa, Russian Federation)

    Objective: The study aims to show that effective and safe bilateral MRgFUS treatment of ET is achievable. Background: Unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy reduces…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley